This study presents a comprehensive analysis of the prevalence of white coat hypertension among adult primary care attendees. White coat hypertension, characterized by elevated blood pressure readings in clinical settings but normal blood pressure levels outside of these environments, poses diagnostic and management challenges in clinical practice. The study examines data from a large cohort of adult primary care attendees, analyzing blood pressure measurements obtained in clinical settings and through ambulatory monitoring. By comparing the prevalence of white coat hypertension between these two modalities, the study sheds light on the magnitude of the phenomenon and its implications for hypertension diagnosis and management. Additionally, factors contributing to the occurrence of white coat hypertension are explored, including patient demographics, clinical characteristics, and health outcomes. The findings contribute to a better understanding of white coat hypertension prevalence and inform strategies for its recognition and management in primary care settings.

White coat hypertension, prevalence, primary care

Clinical Guideline 127: Hypertension in adults: Diagnosis and management. National Institute for Health and Care Excellence, 2011.

Pickering TG. White coat hypertension – Should it be treated or not? Cleve Clin J Med. 2002;69(8):584–5.

Martinez MA, Garcia-Puig J, Martin JC, et al. Frequency and determinants of white coat hypertension in mild to moderate hypertension: a primary care-based study. Monitorizacion Ambulatoria de la Presion Arterial (MAPA)-Area 5 Working Group. Am J Hypertens. 1999;12(3):251–9.

Julius S, Jamerson K, Gudbrandsson T, et al. White coat hypertension: a follow-up. Clin Exp Hypertens A. 1992;14(1-2):45–53.

Lemne C, Lindvall K, Georgiades A, et al. Structural cardiac changes in relation to 24h ambulatory blood pressure levels in borderline hypertension. J Intern Med. 1995;238(1):49–57.

Hoegholm A, Bang LE, Kristensen KS, et al. Microalbuminuria in 411 untreated individuals with established hypertension, white coat hypertension, and normotension. Hypertension. 1994;24(1):101–5.

Zhou J, Liu C, Shan P, et al. Characteristics of white coat hypertension in Chinese Han patients with type 2 diabetes mellitus. Clin Exp Hypertens. 2014;36(5):321–5.

Ng CM, Yiu SF, Choi KL, et al. Prevalence and significance of white-coat hypertension and masked hypertension in type 2 diabetics. Hong Kong Med J. 2008;14(6):437–43.

Hwang ES, Choi KJ, Kang DH, et al. Prevalence, predictive factor, and clinical significance of white-coat hypertension and masked hypertension in Korean hypertensive patients. Korean J Intern Med. 2007;22(4):256–62.

Ugajin T, Hozawa A, Ohkubo T, et al. White-coat hypertension as a risk factor for the development of home hypertension: the Ohasama study. Arch Intern Med. 2005;165:1541–6.

Segre CA, Ueno RK, Warde KRJ, et al. White-coat hypertension and normotension in the league of hypertension of the Hospital das Clínicas, FMUSP. Prevalence, clinical and demographic characteristics. Arq Bras Cardiol. 2003;80(2):117–21.